Prelude Therapeutics Incorporated (Nasdaq: PRLD), a precision oncology company, today announced that a poster with preclinical data on the Company’s oral KAT6A selective degrader (PRT13722) has been ...
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custo ...
Cibus, Inc. (Nasdaq: CBUS) (the 'Company'), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced its financial results for the quarter ...
Positive interim Phase 1 data of NEK7-directed MGD MRT-8102 demonstrated profound CRP reductions in elevated CVD-risk subjects; readout of ...
Positive interim Phase 1 data of NEK7-directed MGD MRT-8102 demonstrated profound CRP reductions in elevated CVD-risk subjects; readout of expanded part 3 CRP PoC trial (now called GFORCE-1) anticipat ...
Everyday Health on MSN
GLP-1 and exercise 101: A beginner-friendly approach to staying strong during weight loss
GLP-1 and exercise don't have to feel overwhelming. Learn how to move safely, build strength, and support long-term results.
A Lightweight Self-Supervised Representation Learning Framework for Depression Risk Profiling from Synthetic Daily Behavioural Trajectories ...
A new citizen-science project is investigating a possible universal structural pattern in protein 3D architecture; The pattern involves amino acids clustering by chemical type int ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results